“invivodata was able to deliver us the real-time data that we needed to develop an unbiased view into our patients’ pain experiences. This kind of data cannot be collected with paper diaries.”
Dr. Michael Gendreau
Chief Medical Officer, Cypress Bioscience
In this article, Applied Clinical Trials editor Lisa Henderson reviews the momentum in the pharmaceutical industry toward the use of Patient Reported Outcomes data in clinical trials, including the FDA’s final publication of a Guidance to Industry on the use of PROs and Quintiles’ selection of invivodata as its primary preferred provider of ePRO solutions. Read "Ahead of the ePRO Curve" now.